InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55
United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
Paul B Manning
30 May 2025
10% owner
Buy indirect
750,000
$2.75
$2.06M
Paul B Manning
27 Jun 2024
10% owner
Buy
1,333,333
$2.25
$3.00M
Paul B Manning
17 Nov 2023
10% owner
Buy indirect
100,000
$1.63
$163.00K
Phillip B. Donenberg
16 Aug 2023
Director
Buy
111,111
$0.90
$100.00K
Sean P. Nolan
16 Aug 2023
Chief Executive Officer
Buy indirect
444,444
$0.90
$400.00K
John A Stalfort III
16 Aug 2023
Director
Buy
388,889
$0.90
$350.00K
John A Stalfort III
16 Aug 2023
Director
Buy indirect
388,889
$0.90
$350.00K
Paul B Manning
16 Aug 2023
10% owner
Buy indirect
16,466,667
$0.90
$14.82M
Sukumar Nagendran
16 May 2023
President and Head of R&D
Buy
5,000
$0.68
$3.40K
Paul B Manning
31 Oct 2022
Director
Buy
1,500,000
$2.00
$3.00M
Paul B Manning
3 Feb 2022
Director
Buy indirect
26,602
$7.84
$208.56K
Paul B Manning
3 Feb 2022
Director
Buy
50,000
$7.84
$392.00K
Phillip B. Donenberg
2 Feb 2022
Director
Buy
3,000
$7.78
$23.34K
Sukumar Nagendran
2 Feb 2022
Director
Buy
10,000
$8.01
$80.10K
Paul B Manning
2 Feb 2022
Director
Buy indirect
22,000
$7.77
$170.94K
Paul B Manning
2 Feb 2022
Director
Buy indirect
45,000
$7.77
$349.65K
Paul B Manning
2 Feb 2022
Director
Buy
58,000
$7.77
$450.66K
Paul B Manning
24 Nov 2021
Director
Buy
2,202
$13.19
$29.04K
Paul B Manning
23 Nov 2021
Director
Buy
20,000
$12.54
$250.80K
R.A. Session II
23 Nov 2021
President and CEO
Buy
26,008
$12.65
$329.00K
R.A. Session II
23 Nov 2021
President and CEO
Buy
16,510
$12.12
$200.10K
Sean P. Nolan
20 May 2021
Director
Buy
1,170
$22.35
$26.15K
Paul B Manning
14 May 2021
Director
Buy
12,000
$20.98
$251.76K
Show all 66 transactions →

What was left out

Form 4 filings counted 106
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 5
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 14,986,465
Sales filed before the plan box existed 21
History held since 25 Sep 2020